Finding useful biomarkers for Parkinson's disease

被引:89
作者
Chen-Plotkin, Alice S. [1 ]
Albin, Roger [2 ,3 ,4 ]
Alcalay, Roy [5 ]
Babcock, Debra [6 ]
Bajaj, Vikram [7 ]
Bowman, Dubois [8 ]
Buko, Alex [9 ]
Cedarbaum, Jesse [10 ]
Chelsky, Daniel [11 ]
Cookson, Mark R. [12 ]
Dawson, Ted M. [13 ]
Dewey, Richard [14 ]
Foroud, Tatiana [15 ]
Frasier, Mark [16 ]
German, Dwight [17 ]
Gwinn, Katrina [6 ]
Huang, Xuemei [18 ]
Kopil, Catherine [16 ]
Kremer, Thomas [19 ]
Lasch, Shirley [20 ]
Marek, Ken [20 ]
Marto, Jarrod A. [21 ,22 ,23 ,24 ]
Merchant, Kalpana [25 ]
Mollenhauer, Brit [26 ,27 ]
Naito, Anna [16 ]
Potashkin, Judith [28 ]
Reimer, Alyssa [16 ]
Rosenthal, Liana S. [29 ]
Saunders-Pullman, Rachel [30 ]
Scherzer, Clemens R. [31 ]
Sherer, Todd [16 ]
Singleton, Andrew [32 ]
Sutherland, Margaret [6 ]
Thiele, Ines [33 ]
van der Brug, Marcel [34 ]
Van Keuren-Jensen, Kendall [35 ]
Vaillancourt, David [36 ]
Walt, David [24 ]
West, Andrew [37 ]
Zhang, Jing [38 ]
机构
[1] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] VAAHS, Neurol Serv, Ann Arbor, MI 48105 USA
[3] VAAHS, GRECC, Ann Arbor, MI 48105 USA
[4] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[5] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA
[6] NINDS, NIH, Bethesda, MD 20824 USA
[7] Verily Google Life Sci, San Francisco, CA 94080 USA
[8] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA
[9] Human Metabolome Technol Amer, Boston, MA 02134 USA
[10] Biogen, Cambridge, MA 02142 USA
[11] Caprion Biosci, Montreal, PQ H2X 3Y7, Canada
[12] NIA, Cell Biol & Gene Express Sect, Lab Neurogenet, NIH, Bethesda, MD 20892 USA
[13] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA
[14] Univ Texas Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA
[15] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[16] Michael J Fox Fdn Parkinsons Res, New York, NY 10163 USA
[17] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA
[18] Penn State Univ, Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA
[19] F Hoffmann La Roche Ltd, Pharmaceut Res & Early Dev, NORD Discovery & Translat Area, Roche Innovat Ctr Basel, CH-4070 Basel, Switzerland
[20] Inst Neurodegenerat Disorders, New Haven, CT 06510 USA
[21] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[22] Harvard Med Sch, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02215 USA
[23] Harvard Med Sch, Blais Prote Ctr, Dana Farber Canc Inst, Boston, MA 02215 USA
[24] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA
[25] Chaperone Therapeut, Portland, OR 97229 USA
[26] Paracelsus Elena Klin, D-34128 Kassel, Germany
[27] Univ Med Ctr, D-37075 Gottingen, Germany
[28] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, Chicago, IL 60064 USA
[29] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[30] Icahn Sch Med Mt Sinai, Mt Sinai Beth Israel, Dept Neurol, New York, NY 10003 USA
[31] Harvard Med Sch, Ctr Adv Parkinsons Dis Res & Precis Neurol Progra, Brigham & Womens Hosp, Boston, MA 02115 USA
[32] NIA, Lab Neurogenet, Bethesda, MD 20892 USA
[33] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg
[34] Genentech Inc, San Francisco, CA 94080 USA
[35] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA
[36] Univ Florida, Dept Appl Physiol Biomed Engn & Neurol, Gainesville, FL 32611 USA
[37] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35233 USA
[38] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
PLASMA APOLIPOPROTEIN A1; ALZHEIMERS-DISEASE; DISCOVERY; DISORDERS; SERUM; BETA;
D O I
10.1126/scitranslmed.aam6003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The recent advent of an "ecosystem" of shared biofluid sample biorepositories and data sets will focus biomarker efforts in Parkinson's disease, boosting the therapeutic development pipeline and enabling translation with real-world impact.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] Low clinical diagnostic accuracy of early vs advanced Parkinson disease Clinicopathologic study
    Adler, Charles H.
    Beach, Thomas G.
    Hentz, Joseph G.
    Shill, Holly A.
    Caviness, John N.
    Driver-Dunckley, Erika
    Sabbagh, Marwan N.
    Sue, Lucia I.
    Jacobson, Sandra A.
    Belden, Christine M.
    Dugger, Brittany N.
    [J]. NEUROLOGY, 2014, 83 (05) : 406 - 412
  • [2] Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
    Alcalay, Roy N.
    Levy, Oren A.
    Waters, Cheryl C.
    Fahn, Stanley
    Ford, Blair
    Kuo, Sheng-Han
    Mazzoni, Pietro
    Pauciulo, Michael W.
    Nichols, William C.
    Gan-Or, Ziv
    Rouleau, Guy A.
    Chung, Wendy K.
    Wolf, Pavlina
    Oliva, Petra
    Keutzer, Joan
    Marder, Karen
    Zhang, Xiaokui
    [J]. BRAIN, 2015, 138 : 2648 - 2658
  • [3] CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
    Alves, Guido
    Bronnick, Kolbjorn
    Aarsland, Dag
    Blennow, Kaj
    Zetterberg, Henrik
    Ballard, Clive
    Kurz, Martin Wilhelm
    Andreasson, Ulf
    Tysnes, Ole-Bjorn
    Larsen, Jan Petter
    Mulugeta, Ezra
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (10) : 1080 - 1086
  • [4] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    Atkinson, AJ
    Colburn, WA
    DeGruttola, VG
    DeMets, DL
    Downing, GJ
    Hoth, DF
    Oates, JA
    Peck, CC
    Schooley, RT
    Spilker, BA
    Woodcock, J
    Zeger, SL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 89 - 95
  • [5] Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
    Beach, Thomas G.
    Adler, Charles H.
    Sue, Lucia I.
    Serrano, Geidy
    Shill, Holly A.
    Walker, Douglas G.
    Lue, LihFen
    Roher, Alex E.
    Dugger, Brittany N.
    Maarouf, Chera
    Birdsill, Alex C.
    Intorcia, Anthony
    Saxon-Labelle, Megan
    Pullen, Joel
    Scroggins, Alexander
    Filon, Jessica
    Scott, Sarah
    Hoffman, Brittany
    Garcia, Angelica
    Caviness, John N.
    Hentz, Joseph G.
    Driver-Dunckley, Erika
    Jacobson, Sandra A.
    Davis, Kathryn J.
    Belden, Christine M.
    Long, Kathy E.
    Malek-Ahmadi, Michael
    Powell, Jessica J.
    Gale, Lisa D.
    Nicholson, Lisa R.
    Caselli, Richard J.
    Woodruff, Bryan K.
    Rapscak, Steven Z.
    Ahern, Geoffrey L.
    Shi, Jiong
    Burke, Anna D.
    Reiman, Eric M.
    Sabbagh, Marwan N.
    [J]. NEUROPATHOLOGY, 2015, 35 (04) : 354 - 389
  • [6] An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia
    Berlyand, Yosef
    Weintraub, Daniel
    Xie, Sharon X.
    Mellis, Ian A.
    Doshi, Jimit
    Rick, Jacqueline
    McBride, Jennifer
    Davatzikos, Christos
    Shaw, Leslie M.
    Hurtig, Howard
    Trojanowski, John Q.
    Chen-Plotkin, Alice S.
    [J]. PLOS ONE, 2016, 11 (01):
  • [7] Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases
    Chen-Plotkin, Alice S.
    [J]. NEURON, 2014, 84 (03) : 594 - 607
  • [8] Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
    Cooper, Christine A.
    Jain, Nimansha
    Gallagher, Michael D.
    Weintraub, Daniel
    Xie, Sharon X.
    Berlyand, Yosef
    Espay, Alberto J.
    Quinn, Joseph
    Edwards, Karen L.
    Montine, Thomas
    Van Deerlin, Vivianna M.
    Trojanowski, John
    Zabetian, Cyrus P.
    Chen-Plotkin, Alice S.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (01): : 15 - 25
  • [9] Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers
    Fraser, Kyle B.
    Moehle, Mark S.
    Alcalay, Roy N.
    West, Andrew B.
    [J]. NEUROLOGY, 2016, 86 (11) : 994 - 999
  • [10] Biomarker enrichment strategies: matching trial design to biomarker credentials
    Freidlin, Boris
    Korn, Edward L.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (02) : 81 - 90